Citius Oncology Inc
NASDAQ:CTOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Citius Oncology Inc
NASDAQ:CTOR
|
US |
|
Frontier Developments PLC
LSE:FDEV
|
UK |
|
T
|
Toray Industries Inc
OTC:TRYIY
|
JP |
|
M
|
Mogo Inc
F:SGCC
|
CA |
|
W
|
Wartsila Oyj Abp
DUS:MTA
|
FI |
|
Metrospaces Inc
OTC:MSPC
|
US |
|
E
|
E Pairis SA
ATHEX:PAIR
|
GR |
|
C
|
CareCloud Inc
NASDAQ:CCLD
|
US |
|
I
|
Isu Petasys Co Ltd
KRX:007660
|
KR |
|
D
|
Daol Investment Co Ltd
KOSDAQ:298870
|
KR |
|
T
|
Tharisa PLC
JSE:THA
|
CY |
Wall Street
Price Targets
CTOR Price Targets Summary
Citius Oncology Inc
According to Wall Street analysts, the average 1-year price target for CTOR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CTOR's stock price target?
Price Target
6.12
USD
According to Wall Street analysts, the average 1-year price target for CTOR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.